The uncertainties created by relying on the vague 'Competition on the merits' standard in the pharmaceutical sector

The Italian Pfizer/Pharmacia case

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Pages (from-to)344-352
Number of pages9
JournalJournal of European Competition Law & Practice
Volume5
Issue number6
Publication statusPublished - 2014

Cite this

@article{9a1f6168e3d245faa73d393834bddd3c,
title = "The uncertainties created by relying on the vague 'Competition on the merits' standard in the pharmaceutical sector: The Italian Pfizer/Pharmacia case",
author = "Damien Geradin",
year = "2014",
language = "English",
volume = "5",
pages = "344--352",
journal = "Journal of European Competition Law & Practice",
issn = "2041-7764",
number = "6",

}

TY - JOUR

T1 - The uncertainties created by relying on the vague 'Competition on the merits' standard in the pharmaceutical sector

T2 - The Italian Pfizer/Pharmacia case

AU - Geradin, Damien

PY - 2014

Y1 - 2014

M3 - Article

VL - 5

SP - 344

EP - 352

JO - Journal of European Competition Law & Practice

JF - Journal of European Competition Law & Practice

SN - 2041-7764

IS - 6

ER -